Article
Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity.
Pituitary - 1 Jun 2022
Shichi Hiroki, Fukuoka Hidenori, Kanzawa Maki, Yamamoto Masaaki, Yamamoto Naoki, Suzuki Masaki, Urai Shin, Matsumoto Ryusaku, Kanie Keitaro, Fujita Yasunori, Bando Hironori, Iguchi Genzo, Inoshita Naoko, Yamada Shozo, Takahashi Yutaka, Ogawa Wataru
Abstract excerpt
PURPOSE: To clarify the characteristics of Cushing's disease (CD) patients who respond to the desmopressin (DDAVP) test and its underlying mechanisms. METHODS: Forty-seven patients with CD who underwent DDAVP testing were included. Patients were divided into two groups: DDAVP test (+) (adrenocorticotropic hormone [ACTH] levels increased by ≥ 1.5-fold during the DDAVP test) and DDAVP test (-) (ACTH levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
